The Senate passed the Feinstein-Mikulski amendment late last night. This amendment provides an additional $390 million in cancer funding, with increases of:
- $240 million for the NCI
- $4.6 million for the National Center on Minority Health and Health Disparities
- $117 million for cancer programs at the CDC
- $25 million for the Nurse Reinvestment Act and Nursing Programs at HRSA
“Coming on the heels of our dramatic victory yesterday on the Specter Harkin amendment, we have accomplished much in a very difficult fiscal environment. The success of both these amendments puts the United States Senate clearly on record strongly opposing the President’s cuts to cancer funding, and will greatly strengthen our negotiating position as we enter the all important appropriations process this summer and fall,” says Dan Smith, VP of the American Cancer Society and Chair of One Voice Against Cancer.
“The Senate has a track record of supporting cancer research and prevention,” says Nancy Roach, C3 President. “The House will be a challenge. Stay tuned!”
See Senator Feinstein’s press release
Leave a Reply
Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. FightCRC is not responsible for the medical accuracy of any comments left by persons other than FightCRC staff members. FightCRC staff members monitor comments and may respond publicly where appropriate.
Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.
We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).